# Pivotal Study in Advanced Parkinsons Disease Patients

> **NCT00466167** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 517 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Pramipexol Extended Release
- **DRUG:** Pramipexol Immediate Release
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00466167
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-11
- **Final completion:** —
- **Target enrollment:** 517 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466167, "Pivotal Study in Advanced Parkinsons Disease Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00466167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*